Imricor Medical Systems, Inc. announced the appointment of Mr. Gregg Stenzel to the new role of Chief Operating Officer, effective 1 January 2021. In this newly established role, Mr. Stenzel will lead the execution of company's strategic plan across most functional areas of the business, providing greater capacity for CEO, Steve Wedan, to drive the establishment of new clinical sites as the business accelerates the commercial roll out of its products across Europe in 2021. Mr. Stenzel was previously Imricor's Vice President of Operations.